{
    "Overall_score": {
        "Correlation": 7,
        "Sentiment": 6,
        "Importance": 5,
        "Impact": 6,
        "Duration": 4,
        "Virality": 3,
        "Source_Score": 5,
        "Specificity": 6,
        "Sector_Spread": 7,
        "Tech_Mentions": 2
    },
    "Each_item": [
        {
            "News_content": "JNJ Johnson & Johnson Day Low $JNJ $TRX $XME $CURE #JNJ #stocks #pennystocks",
            "Correlation": 8,
            "Sentiment": 4,
            "Importance": 3,
            "Impact": 4,
            "Duration": 3,
            "Virality": 2,
            "Source_Score": 5,
            "Specificity": 7,
            "Sector_Spread": 6,
            "Tech_Mentions": 1
        },
        {
            "News_content": "JNJ Johnson & Johnson News $JNJ $NHC.TO $BIB $XLV #JNJ #nasdaq #invest",
            "Correlation": 7,
            "Sentiment": 5,
            "Importance": 4,
            "Impact": 5,
            "Duration": 4,
            "Virality": 3,
            "Source_Score": 6,
            "Specificity": 6,
            "Sector_Spread": 7,
            "Tech_Mentions": 2
        },
        {
            "News_content": "$TGTX $ABBV $JNJ Jeff Sharman excellent job 121 sites now enrolling up from 81 few weeks ago",
            "Correlation": 6,
            "Sentiment": 8,
            "Importance": 7,
            "Impact": 7,
            "Duration": 5,
            "Virality": 4,
            "Source_Score": 5,
            "Specificity": 8,
            "Sector_Spread": 5,
            "Tech_Mentions": 1
        },
        {
            "News_content": "Errrr…hmm…ok…Daily Mail notes speculation Glaxo may face approach from Roche or J&J at about 1900p/shr. $GSK $JNJ",
            "Correlation": 7,
            "Sentiment": 6,
            "Importance": 8,
            "Impact": 8,
            "Duration": 6,
            "Virality": 5,
            "Source_Score": 7,
            "Specificity": 7,
            "Sector_Spread": 8,
            "Tech_Mentions": 1
        }
    ]
}